Otsuka Holdings
在场
是其中之一......
Otsuka Holdings 是一家在股票代码 4578 (JP) 下上市的公司。
Otsuka Holdings 在 10 个国家有直接业务。Otsuka Holdings 拥有 25家子公司，其中包括 Astex、Astex Pharmaceuticals 和 Cambridge Isotope Laboratories。
他们在：
高管
查看带有其 243 名主要高管的组织结构图
Otsuka Holdings 搜索最多的简介
- Tatsuo Higuchi, President, Chief Executive Officer, Chairman of Th...
- Yukio Matsutani, Independent Director
- Ko Sekiguchi, Independent Director
创建提醒
跟踪 Otsuka Holdings 的高管变动
健康
Otsuka Holdings 拥有 1,965 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Radon Medical Imaging 已收购 Alpha Imaging (公布2024十一月20号).
- TowerBrook Capital Partners 已收购 R1 RCM (公布2024十一月19号).
- Kewaunee Scientific 已收购 Nu Aire (公布2024十一月6号).
健康 行业的其他推荐联系人
消息
Otsuka Holdings 的最新新闻稿
- Otsuka Announces Positive Interim Results from the Phase 3 Trial of Sibeprenlimab for the Treatment of Immunoglobulin A Nephropathy in Adults｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Group Establishes Solar Power Generation Facility in Naka, Tokushima The New Facility Advances the Company’s Carbon Neutrality Initiative | Otsuka Group News | Otsuka Holdings Co., Ltd.searchsearchBack ButtonSearch IconFilter Icon
- HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight® hematological malignancies gene panel test approved in Japan -｜News Releases | Otsuka Pharmaceutical C
- Otsuka Receives Approval in Japan for Lupkynis® as a Treatment for Lupus Nephritis｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Completes Acquisition of Jnana Therapeutics Inc.｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Heartful Kawauchi ReceivedJapan Organization for Employment of the Elderly, Persons with Disabilities and Job Seekers President's Award｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Advancing Women's Health Business Bonafide Health Launched "Thermella", a Plant-derived Supplement to Support Menopausal Women in the U.S.｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Obtains Additional Indication for Rexulti®in Japan as an Adjunctive Treatment for Agitation Associated with Dementia due to Alzheimer's Disease｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka to Participate in the Orange Innovation Project, Promoted by Japan's Ministry of Economy, Trade and Industry｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- Otsuka Pharmaceutical Launches Corporate Health Support Program "fitbiz"Supporting Employees in Building and Maintaining Healthy Habits｜News Releases | Otsuka Pharmaceutical Co., Ltd.
- View more press releases Close
通过电子邮件
